Secondly, in our study, we detected anti-MDA5 Ab in limited number (274) of COVID-19 patients and we could not obtain sufficient consecutive samples due to limited supportive resources in the early stage of SARS-CoV-2 outbreak. The gene discussed is IFIH1; the disease is COVID-19.